- This topic has 1 voice and 0 replies.
Viewing 0 reply threads
-
Posts
-
-
A single dose of Translate Bio’s first-in-class mRNA therapy MRT5005 may improve lung function in cystic fibrosis, interim Phase 1/2 trial data shows. Click here to read more about it.
What are your thoughts about this study and its findings?
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.
